Groundbreaking developments in GLP-1 are centered on novel delivery methods, particularly the development of rapidly disintegrating pills. These new formats intend to increase user compliance and potentially provide quicker uptake, contributing to better health effects. Researchers hypothesize that this technology presents significant potential for